|
|
||||||||
J Thorac Cardiovasc Surg 1998;116:554-559
© 1998 Mosby, Inc.
GENERAL THORACIC SURGERY |
Berlin, Germany
From the Charitè University Hospital, Robert Rössle Hospital and Tumor Institute, Humboldt University, Berlin, Germany.
Received for publication Dec 19, 1997. Revisions requested March 17, 1998; revisions received April 23, 1998. Accepted for publication April 24, 1998. Address for reprints: P. M. Schlag, MD, Department of Surgery and Surgical Oncology, Robert-Rössle Hospital and Tumor Institute, Humboldt University, Lindenbergerweg 80, 13122 Berlin, Germany.
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
In recent years endoscopic ultrasound (EUS) has been increasingly used for staging of esophageal cancer. This technique provides high-resolution images of the intestinal wall and the paraesophageal region. Generally the sensitivity of EUS in the detection of mediastinal lymph node involvement approximates 80%, and there is some evidence that EUS is more accurate than computed tomography (69% vs 51%).
4 However, it remains difficult to distinguish malignant and benign lesions reliably. The specificity of EUS in the identification of metastatic lymph node involvement ranges between 50% and 70%.
5 Therefore mediastinal biopsy is still necessary to achieve a precise diagnosis of mediastinal lesions.
6
Recently echoendoscopes with linear-array transducers have been developed that allow EUS-guided biopsy of extraluminal lesions.
7 However, as yet mainly preliminary information is available on the relevance of this new method for the evaluation of mediastinal tumors.
7-9 The purpose of this prospective study was to investigate the value of EUS-guided biopsy for the diagnosis of mediastinal lesions.
| Patients and methods |
|---|
|
|
|---|
For EUS the patients were placed in the left lateral decubitus position. Midazolam (3-5 mg) was administered intravenously for conscious sedation. A 60-degree oblique viewing fiberoptic endoscope (Pentax FG 32UA, Pentax, Hamburg, Germany) with a curved array transducer (7.5 MHz) was used for all examinations. The 100-degree scan plane of the transducer is oriented along the longitudinal axis of the endoscope, which allows real-time visualization of the biopsy needle. EUS images were displayed on a CS9600 ultrasound unit (Ecoscan, Wiesbaden, Germany).
A specially designed needle device (Mandel & Rupp, Erkrath, Germany) was used for EUS-guided aspiration biopsy.
10 The device consists of a 140-cm long stainless steel needle with a diameter of 0.8 mm, which is guided through a 5F metal sheath. The biopsy needle can be advanced with a handle. When a lesion was displayed with EUS, catheter and needle were passed through the working channel until the catheter just reached the viewing field. Then the needle was filled with sterile saline solution and introduced into the target. Fine needle aspiration biopsy was achieved by applying suction with a 5-ml syringe while the needle was advanced and withdrawn several times. Generally 4 to 6 passes were required to obtain adequate tissue samples. The duration of the whole procedure ranged between 10 and 20 minutes.
The biopsy specimens were placed in formaldehyde. Conventional staining was used for histologic analysis. Additionally, immunohistochemistry was performed in selected cases if the results of routine staining were inconclusive.
All patients underwent a follow-up program with examinations every 3 months. Progressive disease confirmed malignancy in all patients whose biopsy specimens had histologic characteristics of malignant disease. Surgery was performed in 4 of 6 patients with benign histologic characteristics and confirmed the diagnosis in all cases. In the 2 remaining patients with a history of cancer (esophageal cancer and non-Hodgkin's lymphoma) and benign histologic characteristics, there is no evidence of malignancy after follow-up periods of 9 and 7 months, respectively.
| Results |
|---|
|
|
|---|
|
|
|
|
|
The overall sensitivity and specificity of EUS-guided biopsy for the diagnosis of malignancy were 89% and 83%, respectively. The positive predictive value was 100% and the negative predictive value was 75%. The procedure was well tolerated by the patients and no complications were observed related to transesophageal biopsy.
| Discussion |
|---|
|
|
|---|
The development of echoendoscopes with curved array transducers offers a new modality for ultrasound-guided biopsy of mediastinal lesions. However, as yet only limited experience has been gained with this method, mainly because of the lack of appropriate biopsy needles.
In our experience, EUS with fine needle aspiration proved to be a very safe and accurate method for tissue sampling of mediastinal lesions. This technique provides access to regions that are not easily accessible by cervical mediastinoscopy, that is, the posterior and inferior mediastinum. However, visualization of lesions in the anterior mediastinum is not possible because the air-filled trachea prevents ultrasound transmission.
Real-time ultrasound visualization of the biopsy procedure enabled highly precise biopsy of small lesions even in direct proximity to major vessels. Overall, diagnostic biopsy specimens were obtained in 88% of the cases (sensitivity, 89%; specificity, 83%). The high accuracy of EUS-guided biopsy of mediastinal tumors compares favorably with the results reported for gastrointestinal tumors. In a group of 45 patients with pancreatic tumors, Faigel and associates
17 reached a rate of 91% diagnostic fine needle aspirations under EUS guidance. Giovanini and coworkers
18 achieved a sensitivity of 77% and a specificity of 100% in the detection of malignancy in 141 patients with various tumors. Recently, encouraging results of EUS-guided biopsy of mediastinal tumors have been presented in a preliminary report.
19 A conclusive cytologic study was obtained and confirmed in 12 of 13 lesions. In contrast to this and some other studies,
7,20 in our study the diagnosis was based on histologic analysis and not on cytologic examination. The size and the quality of the tissue samples were sufficient for routine staining and histopathologic assessment of the biopsy specimen. It is remarkable that immunohistochemistry could also be performed in some cases to specify the diagnosis.
Ultrasound-guided biopsy greatly increased the accuracy of EUS in the classification of mediastinal lymph nodes (ie, malignant vs benign). Histologic study disclosed a false positive EUS diagnosis in 3 of 13 patients with suspected malignant lymph nodes. On the other hand, metastatic spread was found in 1 of 3 patients although benign lymph nodes were suggested by EUS. These data demonstrate that EUS-guided biopsy is capable of improving the staging of mediastinal lymph nodes, which can be of major importance for the therapeutic strategy in patients with thoracic tumors.
Recently, Silvestri and associates
21 evaluated the utility of this modality for staging of lung cancer in 27 patients. EUS-guided fine needle aspiration biopsy enabled detection of lymph node metastases with a sensitivity of 89%. It has also been reported that this technique is more accurate in the assessment of lymph node involvement from lung cancer than computed tomography (95% vs 43%).
22 Surgery was abandoned in 59% of the patients, because mediastinal lymph node metastases were established by transesophageal biopsy.
Besides improved staging of known primary tumors, EUS-guided biopsy can provide a histopathologic diagnosis of indeterminate mediastinal tumors that are not accessible for other nonsurgical techniques, for example, bronchoscopy. In this study biopsy confirmed the suspected diagnosis in 19 of 27 patients, whereas an unexpected diagnosis was disclosed in 8 patients (30%). Notably, biopsy did not confirm metastases in 2 patients with suspicious mediastinal lymph nodes and a history of cancer. In a patient with a melanoma, biopsy showed an intrathoracic goiter, whereas a secondary tumor (lymphoma) was found in a patient with a hypernephroma. These findings support the need for histologic confirmation of the diagnosis even in apparently clear cases.
We have not observed any complications related to EUS-guided biopsy. However, needle tract seeding can occur after transcutaneous needle biopsy of malignant tumors. In a follow-up survey involving 95,000 fine needle biopsies, metastases in the biopsy canal were observed in only 6 cases (0.006%).
23 Overall, the risk of tumor cell dissemination by fine needle biopsy seems to be low. Nonetheless, we would suggest that EUS-guided biopsy be preferentially applied to patients with nonresectable or metastatic disease.
In conclusion, EUS with ultrasound-guided biopsy is a valuable method for the diagnostic evaluation of mediastinal tumors and the staging of lymph nodes. This minimally invasive technique allows precise tissue sampling of lesions in the posterior mediastinum. In selected cases, EUS-guided biopsy can obviate the need for diagnostic surgical procedures, that is, mediastinoscopy and thoracoscopy.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. A. Eloubeidi, A. Tamhane, V. K. Chen, and R. J. Cerfolio Endoscopic Ultrasound-Guided Fine-Needle Aspiration in Patients With Non-Small Cell Lung Cancer and Prior Negative Mediastinoscopy Ann. Thorac. Surg., October 1, 2005; 80(4): 1231 - 1239. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Bhutani, D. V. Jones Jr, and J. B. Zwischenberger Endoscopic Ultrasound-Guided Fine-Needle Aspiration Staging of Lung Cancer: Is It Time To Go Beyond Cytology? Chest, February 1, 2005; 127(2): 418 - 420. [Full Text] [PDF] |
||||
![]() |
J. K. LeBlanc, B. M. Devereaux, T. F. Imperiale, K. Kesler, J. M. DeWitt, O. Cummings, D. Ciaccia, S. Sherman, P. Mathur, D. Conces, et al. Endoscopic Ultrasound in Non-Small Cell Lung Cancer and Negative Mediastinum on Computed Tomography Am. J. Respir. Crit. Care Med., January 15, 2005; 171(2): 177 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yasufuku, M. Chiyo, Y. Sekine, P. N. Chhajed, K. Shibuya, T. Iizasa, and T. Fujisawa Real-time Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration of Mediastinal and Hilar Lymph Nodes Chest, July 1, 2004; 126(1): 122 - 128. [Abstract] [Full Text] [PDF] |
||||
![]() |
I Penman and R J Fergusson Endoscopic ultrasound: a useful tool to assess the mediastinum in patients with lung cancer? Thorax, February 1, 2002; 57(2): 95 - 96. [Full Text] [PDF] |
||||
![]() |
S S Larsen, M Krasnik, P Vilmann, G K Jacobsen, J H Pedersen, P Faurschou, and K Folke Endoscopic ultrasound guided biopsy of mediastinal lesions has a major impact on patient management Thorax, February 1, 2002; 57(2): 98 - 103. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Wiersema, E. Vazquez-Sequeiros, and L. M. Wiersema Evaluation of Mediastinal Lymphadenopathy with Endoscopic US-guided Fine-Needle Aspiration Biopsy Radiology, April 1, 2001; 219(1): 252 - 257. [Abstract] [Full Text] |
||||
![]() |
P. Biro, M. Layer, H. D. Becker, F. Herth, K. Wiedemann, B. Seifert, and D. R. Spahn Influence of airway-occluding instruments on airway pressure during jet ventilation for rigid bronchoscopy Br. J. Anaesth., September 1, 2000; 85(3): 462 - 465. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Bhutani Transesophageal Endoscopic Ultrasound-Guided Mediastinal Lymph Node Aspiration : Does the End Justify the Means? Chest, February 1, 2000; 117(2): 298 - 301. [Full Text] [PDF] |
||||
![]() |
A. Fritscher-Ravens, N. Soehendra, L. Schirrow, P. V. J. Sriram, A. Meyer, H.-P. Hauber, and A. Pforte Role of Transesophageal Endosonography-Guided Fine-Needle Aspiration in the Diagnosis of Lung Cancer Chest, February 1, 2000; 117(2): 339 - 345. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |